Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III: a database of mutations.

D A Lane1, H Ireland, R J Olds

  • 1Department of Haematology, Charing Cross and Westminster Medical School, Hammersmith, London, United Kingdom.

Thrombosis and Haemostasis
|December 2, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop and Go: Barriers and Facilitators to Care Home Research.

The Journal of frailty & aging·2023
Same author

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

Journal of thrombosis and haemostasis : JTH·2018
Same author

ADAMTS-13 and von Willebrand factor: a dynamic duo.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Journal of internal medicine·2017
Same author

Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: reply.

Journal of thrombosis and haemostasis : JTH·2017

Researchers have created a database to track mutations causing antithrombin III deficiency. This database catalogs 94 mutations, including 38 novel ones, aiding the study of this genetic disorder.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Antithrombin III deficiency is a genetic disorder that increases the risk of thrombosis.
  • Understanding the molecular basis of this deficiency is crucial for diagnosis and treatment.
  • Previous research has identified various mutations responsible for antithrombin III deficiency.

Purpose of the Study:

  • To establish a comprehensive database of molecular defects causing antithrombin III deficiency.
  • To document and track newly identified and previously reported mutations.
  • To provide a resource for researchers studying antithrombin III gene mutations.

Main Methods:

  • Compilation of a database of antithrombin III gene mutations.
  • Inclusion of sequence polymorphisms and mutations causing functional deficiency.

Related Experiment Videos

  • Annual updates planned for the database.

    • Main Results:

    • The database currently lists 6 antithrombin III locus sequence polymorphisms.
    • A total of 94 mutations causing functional deficiency are recorded.
    • 38 of these recorded mutations are novel, representing new discoveries.

    Conclusions:

    • The compiled database serves as a valuable, annually updated resource for antithrombin III research.
    • The findings highlight common mutation patterns, such as CG to TG or CA changes.
    • Continued database development will facilitate a deeper understanding of antithrombin III deficiency genetics.